Biogen Idec

Evotec will use its expertise and technologies in protein production, assay development and high throughput screening to identify hit molecules for Biogen Idec. Under the research agreement Evotec will screen a target selected by Biogen Idec with the option to add further targets as agreed. Evotec will provide Biogen Idec with access to its full range of screening technologies and diverse library of high quality compounds and will use its expertise in protein production and assay development to develop new assays for the target.

Evotec has built a comprehensive platform of hit finding technologies that allow it to screen challenging targets and identify new classes of hit compounds that can be progressed towards new treatments for various diseases. These proven screening technologies coupled with Evotec's high quality screening library have been shown to unlock numerous biological targets and identify excellent starting points for subsequent optimization.

09 Sep 2009
Evotec announces Research Agreement with Biogen Idec

Further Information

Integrated Services.pdf
(pdf - 56,68 kB)

Assay Development & Screening.pdf
(pdf - 520,11 kB)

Fragment-based Drug Discovery.pdf
(pdf - 876,2 kB)

Medicinal Chemistry and Early Develop...
(pdf - 90,85 kB)

ADMET & Zebrafish Screening.pdf
(pdf - 75,19 kB)

May 21, 2012
08:48 PM CET